SHARE CAPITAL (Tables)

9 Months Ended

Sep. 30, 2022

Equity [Abstract]

SCHEDULE OF SHARE CAPITAL

	Nine months ended September 30, 2022
	# of shares		Amount
Common shares issued for bonuses and compensation		184,563	$	432,054
Common shares issued for conversion of convertible debt		67,568		131,532
Common shares issued to consultants		259,767		801,457
Total common shares issued		511,898	$	1,365,043

	Nine months ended September 30, 2021
	# of shares		Amount
Common shares issued for cash		3,127,998	$	13,262,712
Common shares issued for conversion of series A preferred stock		2,258,826		6,717,873
Common shares issued on exercise of warrants		39,800		238,800
Common shares issued on cashless exercise of options		820,029		-
Common shares issued for bonus		98,356		514,066
Common shares issued for consulting services		62,237		349,809
Common shares issued for settlement of accrued director’s fee		19,992		46,783
Common shares issued for dividend on preferred shares		189,004		735,932
Share issue costs		-		(2,099,842	)
Total common shares issued		6,616,242	$	19,766,133

SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES

Potentially dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive are as follows (in common equivalent shares):

	September 30, 2022		September 30, 2021
Warrants		9,876,680		5,864,200
Options		635,569		724,037
Convertible debentures		5,744,595		-
Total anti-dilutive weighted average shares		16,256,844		6,588,237